These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1901721)

  • 21. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
    J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.
    Wyatt LS; Earl PL; Liu JY; Smith JM; Montefiori DC; Robinson HL; Moss B
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):645-53. PubMed ID: 15242542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular localization of recombinant vaccinia virus produced HIV antigens and their use for confirmation of HIV seropositivity.
    Bukrinsky MI; Vzorov AN; Bukrinskaya AG
    Acta Virol; 1990 Sep; 34(5):487-92. PubMed ID: 1981459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient human immunodeficiency virus ( HIV)-1 Gag-Env pseudovirion formation elicited from mammalian cells by a canarypox HIV vaccine candidate.
    Fang ZY; Kuli-Zade I; Spearman P
    J Infect Dis; 1999 Oct; 180(4):1122-32. PubMed ID: 10479139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response of mice infected with recombinant vaccinia viruses carrying the HIV gag gene.
    Sugata F; Aoki N; Shioda T; Hayashi T; Shimada K; Mitamura K; Shibuta H
    Microbiol Immunol; 1991; 35(10):849-61. PubMed ID: 1779889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
    Flexner C; Broyles SS; Earl P; Chakrabarti S; Moss B
    Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
    Richmond JF; Mustafa F; Lu S; Santoro JC; Weng J; O'Connell M; Fenyö EM; Hurwitz JL; Montefiori DC; Robinson HL
    Virology; 1997 Apr; 230(2):265-74. PubMed ID: 9143282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
    Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA packaging signal of human immunodeficiency virus type 1.
    Hayashi T; Shioda T; Iwakura Y; Shibuta H
    Virology; 1992 Jun; 188(2):590-9. PubMed ID: 1585635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
    Smith JM; Amara RR; McClure HM; Patel M; Sharma S; Yi H; Chennareddi L; Herndon JG; Butera ST; Heneine W; Ellenberger DL; Parekh B; Earl PL; Wyatt LS; Moss B; Robinson HL
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):654-65. PubMed ID: 15242543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of noninfectious HIV-1 virus particles lacking a full-length envelope protein.
    Ratner L; Vander Heyden N; Garcia J; Polinsky M; Westervelt P; Becich M
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):287-94. PubMed ID: 1829617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of recombinant Modified Vaccinia Ankara Viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice.
    Kumar S; Seth P
    Viral Immunol; 2004; 17(4):574-9. PubMed ID: 15671754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells.
    Owens RJ; Dubay JW; Hunter E; Compans RW
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3987-91. PubMed ID: 2023946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural characterization of human immunodeficiency virus type 1 Gag-containing particles assembled in a recombinant adenovirus vector system.
    Vernon SK; Murthy S; Wilhelm J; Chanda PK; Kalyan N; Lee SG; Hung PP
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1243-51. PubMed ID: 2045790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.